▪ SOX11 expression is restricted to EBV-negative Burkitt lymphoma and associates with molecular genetic features (Apr 14, 2024)

▪ L-DEP regimen salvage therapy for refractory primary hemophagocytic lymphohistiocytosis triggered by Epstein-Barr virus infection in 4 children (Apr 15, 2024)

▪ Epstein-Barr Virus-Positive Mucocutaneous Ulcer on the Gingiva of a Patient in Whom Immunosuppressive Drugs Could Not Be Withdrawn: A Case Report and Review of the Literature (Apr 14, 2024)

▪ Latent Epstein-Barr virus infection collaborates with Myc over-expression in normal human B cells to induce Burkitt-like Lymphomas in mice (Apr 14, 2024)

▪ The Prevalence of Epstein - Barr Virus in Normal, Premalignant, and Malignant Uterine Cervical Samples in Iran (Apr 14, 2024)

▪ Tabelecleucel for EBV+ PTLD following allogeneic HCT or SOT in a multicenter expanded access protocol (Apr 15, 2024)

▪ Inherited KDM6A^A649T facilitates tumor-immune escape and exacerbates colorectal signet-ring cell carcinoma outcomes (Apr 14, 2024)